AB, K., B, C., P, S. E. S., C, P., R, K., J, G., . . . R, C. (2018). Redirection to the bone marrow improves T cell persistence and antitumor functions. The Journal of clinical investigation, 128(5), 2010. https://doi.org/10.1172/JCI97454
Chicago Style (17th ed.) CitationAB, Khan, et al. "Redirection to the Bone Marrow Improves T Cell Persistence and Antitumor Functions." The Journal of Clinical Investigation 128, no. 5 (2018): 2010. https://doi.org/10.1172/JCI97454.
MLA (9th ed.) CitationAB, Khan, et al. "Redirection to the Bone Marrow Improves T Cell Persistence and Antitumor Functions." The Journal of Clinical Investigation, vol. 128, no. 5, 2018, p. 2010, https://doi.org/10.1172/JCI97454.
Warning: These citations may not always be 100% accurate.